# Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity

> **NCT05026164** · PHASE2 · COMPLETED · sponsor: **Canopy Growth Corporation** · enrollment: 40 (actual)

## Conditions studied

- Delayed Onset Muscle Soreness (DOMS)

## Interventions

- **DIETARY_SUPPLEMENT:** CHI-202
- **DIETARY_SUPPLEMENT:** CHI-101

## Key facts

- **NCT ID:** NCT05026164
- **Lead sponsor:** Canopy Growth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-13
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05026164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05026164, "Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05026164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*